Loading clinical trials...
Loading clinical trials...
Thromboelastography-guided Fluid Management in Spinal Surgery: A Prospective Analysis
The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.
Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.
Age
18 - 89 years
Sex
ALL
Healthy Volunteers
No
Mayo Clinic
Scottsdale, Arizona, United States
Start Date
January 12, 2018
Primary Completion Date
November 8, 2019
Completion Date
November 8, 2019
Last Updated
February 2, 2021
50
ACTUAL participants
Intervention
PROCEDURE
Control Group
OTHER
Lead Sponsor
Mayo Clinic
NCT06282770
NCT06820190
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions